The pharmaceutical and biotech industries are trying to get the
US Patent and Trademark Office (USPTO) to change patent law about natural
substances. After a 2013 Supreme Court decision, the biotech industry in
particular advocated a less restrictive approach to patenting natural
substances, and it appears that the USPTO is bowing to industry pressure,
because the agency is considering a new framework to determine the
patentability of products of nature.
The change in rules would clearly open up new pathways for
Big Pharma and biotech firms to patent natural substances. Drug companies will
once again try to monopolize previously affordable substances (like
bioidentical estriol and 17P) and then jack up the price, and essentially
“steal” natural supplements, as they did with pyridoxamine. Another drug
company is looking to snatch up P5P (pyridoxal-5’-phosphate), another natural
form of vitamin B6. Their attempt has been unsuccessful—so far. If patent laws
are weakened, we can expect an increase in efforts by Big Pharma to gain
exclusive rights over natural supplements.
Tell USPTO to keep restrictions in place that prevent
natural substances from being patented. Please send your message immediately—public
comments close on March 16.
Please personalize and add your own comments if you have time!
Keep Natural Substances from Being Patented!
Dear [Decision Maker],
Sincerely,[Your Name] [Your Address] [City, State ZIP]